Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery (vol 29, pg 199, 2021)-MedSci.cn - 梅斯（MedSci）

Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery (vol 29, pg 199, 2021)

Zameer, S; Ali, J; Vohora, D; Najmi, AK; Akhtar, M

JOURNAL OF DRUG TARGETING, 2023; 31 (2):

科室
- - 订阅+
  - 更多科室
工具
服务